Conference Coverage

New research holds promise for fighting obesity, says expert


 

AT INTERNAL MEDICINE 2022

Medication costs are too high for many patients

Isis Smith, MD, an internist at University Medical Center in New Orleans, said in an interview that the cost of the most effective medications – which are not covered by Medicaid – means that many of her patients don’t have access to these treatments.

“We’re talking about $1,000 a month. And so there is no way they can afford [them]. I can prescribe phentermine [but] unless a patient has another indication, Medicaid will not pay for it,” she explained.

“I love hearing about all of the new developments. ... It’s interesting to hear, but we need to get insurance to pay so that I can actually prescribe,” Dr. Smith noted.

Dr. Apovian reports financial relationships with Xeno Biosciences, Cowen, Allergan, Novo Nordisk, Abbott Nutrition, and other companies.

Pages

Recommended Reading

Food insecurity linked to metabolic syndrome in Hispanic/Latino youth
Type 2 Diabetes ICYMI
Maternal obesity promotes risk of perinatal death
Type 2 Diabetes ICYMI
Intermittent fasting good for weight loss, at least short term
Type 2 Diabetes ICYMI
FDA okays semaglutide higher dose, 2 mg/week, for type 2 diabetes
Type 2 Diabetes ICYMI
Be aware of gallbladder, biliary disease with newer obesity drugs
Type 2 Diabetes ICYMI
Cannabis exposure in pregnancy linked with childhood obesity
Type 2 Diabetes ICYMI
Type 2 diabetes remission possible for those with lower BMI
Type 2 Diabetes ICYMI
AHA statement addresses CVD risk in NAFLD
Type 2 Diabetes ICYMI
Bariatric surgery cuts cardiovascular events, even in seniors
Type 2 Diabetes ICYMI
Tirzepatide succeeds in obesity in SURMOUNT-1, says Lilly
Type 2 Diabetes ICYMI